Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha K Manier

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Therapeutic Drug Monitoring|August 20, 2019
Current Situation of the Metabolomics Techniques Used for the Metabolism Studies of New Psychoactive SubstancesSascha K Manier, Markus R Meyer
Metabolomics : Official Journal of the Metabolomic Society|March 4, 2020
Impact of the used solvent on the reconstitution efficiency of evaporated biosamples for untargeted metabolomics studiesSascha K Manier, Markus R Meyer
Drug Testing and Analysis|November 28, 2018
Automated optimization of XCMS parameters for improved peak picking of liquid chromatography-mass spectrometry data using the coefficient of variation and parameter sweeping for untargeted metabolomicsSascha K Manier, Andreas Keller, Markus R Meyer
Journal of Analytical Toxicology|June 8, 2021
Can the Intake of a Synthetic Tryptamine be Detected Only by Blood Plasma Analysis? A Clinical Toxicology Case Involving 4-HO-METLea Wagmann, Sascha K Manier, Markus R Meyer
Scientific Reports|February 28, 2019
Untargeted metabolomics by high resolution mass spectrometry coupled to normal and reversed phase liquid chromatography as a tool to study the in vitro biotransformation of new psychoactive substancesSascha K Manier, Andreas Keller, Jan Schäper, et al.
Drug Testing and Analysis|November 1, 2019
The metabolic fate of two new psychoactive substances - 2-aminoindane and N-methyl-2-aminoindane - studied in vitro and in vivo to support drug testingSascha K Manier, Christina Felske, Niels Eckstein, et al.
Journal of Chromatography. A|May 2, 2024
Impact of four different extraction methods and three different reconstitution solvents on the untargeted metabolomics analysis of human and rat urine samplesSelina Hemmer, Sascha K Manier, Lea Wagmann, et al.
Metabolomics : Official Journal of the Metabolomic Society|April 30, 2024
Comparison of reversed-phase, hydrophilic interaction, and porous graphitic carbon chromatography columns for an untargeted toxicometabolomics study in pooled human liver microsomes, rat urine, and rat plasmaSelina Hemmer, Sascha K Manier, Lea Wagmann, et al.
Journal of Analytical Toxicology|July 30, 2019
Use of UPLC-HRMS/MS for In Vitro and In Vivo Metabolite Identification of Three Methylphenidate-derived New Psychoactive SubstancesSascha K Manier, Sophia Niedermeier, Jan Schäper, et al.
Archives of Toxicology|April 22, 2020
Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adductsSascha K Manier, Lea Wagmann, Veit Flockerzi, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Therapeutic Drug Monitoring|August 20, 2019
Current Situation of the Metabolomics Techniques Used for the Metabolism Studies of New Psychoactive SubstancesSascha K Manier, Markus R Meyer
Metabolomics : Official Journal of the Metabolomic Society|March 4, 2020
Impact of the used solvent on the reconstitution efficiency of evaporated biosamples for untargeted metabolomics studiesSascha K Manier, Markus R Meyer
Drug Testing and Analysis|November 28, 2018
Automated optimization of XCMS parameters for improved peak picking of liquid chromatography-mass spectrometry data using the coefficient of variation and parameter sweeping for untargeted metabolomicsSascha K Manier, Andreas Keller, Markus R Meyer
Journal of Analytical Toxicology|June 8, 2021
Can the Intake of a Synthetic Tryptamine be Detected Only by Blood Plasma Analysis? A Clinical Toxicology Case Involving 4-HO-METLea Wagmann, Sascha K Manier, Markus R Meyer
Scientific Reports|February 28, 2019
Untargeted metabolomics by high resolution mass spectrometry coupled to normal and reversed phase liquid chromatography as a tool to study the in vitro biotransformation of new psychoactive substancesSascha K Manier, Andreas Keller, Jan Schäper, et al.
Drug Testing and Analysis|November 1, 2019
The metabolic fate of two new psychoactive substances - 2-aminoindane and N-methyl-2-aminoindane - studied in vitro and in vivo to support drug testingSascha K Manier, Christina Felske, Niels Eckstein, et al.
Journal of Chromatography. A|May 2, 2024
Impact of four different extraction methods and three different reconstitution solvents on the untargeted metabolomics analysis of human and rat urine samplesSelina Hemmer, Sascha K Manier, Lea Wagmann, et al.
Metabolomics : Official Journal of the Metabolomic Society|April 30, 2024
Comparison of reversed-phase, hydrophilic interaction, and porous graphitic carbon chromatography columns for an untargeted toxicometabolomics study in pooled human liver microsomes, rat urine, and rat plasmaSelina Hemmer, Sascha K Manier, Lea Wagmann, et al.
Journal of Analytical Toxicology|July 30, 2019
Use of UPLC-HRMS/MS for In Vitro and In Vivo Metabolite Identification of Three Methylphenidate-derived New Psychoactive SubstancesSascha K Manier, Sophia Niedermeier, Jan Schäper, et al.
Archives of Toxicology|April 22, 2020
Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adductsSascha K Manier, Lea Wagmann, Veit Flockerzi, et al.
Pageof 3